We have previously shown that 3-nitro-1H-1,2,4-triazole-based amines demonstrate significant trypanocidal activity, in particular against Trypanosoma cruzi, the causative parasite of Chagas disease. In the present work we further expanded our research by evaluating in vitro the trypanocidal activity of nitrotriazole-based piperazines and nitrotriazole-based 2-amino-1,3-benzothiazoles to establish additional SARs. All nitrotriazole-based derivatives were active or moderately active against T. cruzi; however two of them did not fulfill the selectivity criteria. Five derivatives were active or moderately active against Trypanosoma brucei rhodesiense while one derivative was moderately active against Leishmania donovani. Active compounds against T. cruzi demonstrated selectivity indexes (toxicity to host cells/toxicity to T. cruzi amastigotes) from 117 to 1725 and 12 of 13 compounds were up to 39-fold more potent than the reference compound benznidazole. Detailed SARs are discussed.
We have previously shown that 3-nitro-1H-1,2,4-triazole-based amines demonstn class="Species">rate significant trypanocidal activity, in particular against Trypanosoma cruzi, the causative parasite of Chagas disease. In the present work we further expanded our research by evaluating in vitro the trypanocidal activity of nitrotriazole-based piperazines and nitrotriazole-based 2-amino-1,3-benzothiazoles to establish additional SARs. All nitrotriazole-based derivatives were active or moderately active against T. cruzi; however two of them did not fulfill the selectivity criteria. Five derivatives were active or moderately active against Trypanosoma brucei rhodesiense while one derivative was moderately active against Leishmania donovani. Active compounds against T. cruzi demonstrated selectivity indexes (toxicity to host cells/toxicity to T. cruzi amastigotes) from 117 to 1725 and 12 of 13 compounds were up to 39-fold more potent than the reference compound benznidazole. Detailed SARs are discussed.
Authors: Ken Stuart; Reto Brun; Simon Croft; Alan Fairlamb; Ricardo E Gürtler; Jim McKerrow; Steve Reed; Rick Tarleton Journal: J Clin Invest Date: 2008-04 Impact factor: 14.808
Authors: Maria V Papadopoulou; Bernadette Bourdin Trunz; William D Bloomer; Caroline McKenzie; Shane R Wilkinson; Chaiya Prasittichai; Reto Brun; Marcel Kaiser; Els Torreele Journal: J Med Chem Date: 2011-11-04 Impact factor: 7.446
Authors: Els Torreele; Bernadette Bourdin Trunz; David Tweats; Marcel Kaiser; Reto Brun; Guy Mazué; Michael A Bray; Bernard Pécoul Journal: PLoS Negl Trop Dis Date: 2010-12-21
Authors: Maria V Papadopoulou; William D Bloomer; Galina I Lepesheva; Howard S Rosenzweig; Marcel Kaiser; Benjamín Aguilera-Venegas; Shane R Wilkinson; Eric Chatelain; Jean-Robert Ioset Journal: J Med Chem Date: 2015-01-23 Impact factor: 7.446
Authors: Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Alexander Arena; Francisco Arrieta; Joseph C J Rebolledo; Diane K Smith Journal: Antimicrob Agents Chemother Date: 2014-09-02 Impact factor: 5.191
Authors: Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Ana Lia Mazzeti; Karolina Ribeiro Gonçalves; Priscila Fagundes Mendes; Maria Terezinha Bahia Journal: Antimicrob Agents Chemother Date: 2017-04-24 Impact factor: 5.191
Authors: Sarai Martínez-Cerón; Nora Andrea Gutiérrez-Nágera; Elaheh Mirzaeicheshmeh; Roberto I Cuevas-Hernández; José G Trujillo-Ferrara Journal: Parasitol Res Date: 2021-07-01 Impact factor: 2.289
Authors: Robson Xavier Faria; Daniel Tadeu Gomes Gonzaga; Paulo Anastácio Furtado Pacheco; André Luis Almeida Souza; Vitor Francisco Ferreira; Fernando de Carvalho da Silva Journal: J Bioenerg Biomembr Date: 2018-02-23 Impact factor: 2.945
Authors: David U Olveda; Remigio M Olveda; Alfred K Lam; Thao N P Chau; Yuesheng Li; Angelo Don Gisparil; Allen G P Ross Journal: Clin Microbiol Date: 2014-04-15